Table. Patient Demographics and Baseline Characteristics.
| Intervention Group | Control Group | ||
|---|---|---|---|
| Category | (n = 4484) | (n = 1902) | P Value |
| Gender, n (%) | |||
| Female | 2208 (49.2) | 938 (49.3) | .9564 |
| Male | 2276 (50.7) | 964 (50.6) | |
| Age group, n (%), y | |||
| <30 | 48 (1.0) | 26 (1.3) | |
| 30–44 | 293 (6.5) | 161 (8.4) | <.0001 |
| 45–54 | 697 (15.5) | 322 (16.9) | |
| 55–64 | 1284 (28.6) | 637 (33.4) | |
| ≥65 | 2162 (48.2) | 756 (39.7) | |
| Age, mean (SD), y | 61.6 (10.6) | 59.9 (10.9) | <.0001 |
| A1C, mean (SD)a % | 7.25 (1.50) | 7.51 (0.68) | <.0001 |
| At A1C goal, n/N (%) | 1569/2732 (57.4) | 536/1068 (50.1) | <.0001 |
| LDL-C, mean (SD)a, mg/dL | 93.5 (34.5) | 96.7 (37.3) | .0086 |
| At LDL-C goal, n/N (%) | 2211/3513 (62.9) | 717/1227 (58.4) | .0052 |
| Complicationb, n (%) | |||
| Yes | 825 (18.3) | 369 (19.4) | .3477 |
| No | 3659 (81.6) | 1533 (80.5) | |
Abbreviations: A1C, glycated hemoglobin A1c; LDL-C, low-density lipoprotein cholesterol; SD, standard deviation.
aAmong patients with baseline values available.
bPatients with ischemic vascular disease or chronic renal disease or other microvascular diseases.